You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Adam covers proteomics and life science mass spectrometry for GenomeWeb.
High throughput and deep coverage have allowed firms like Olink and Somalogic to make inroads, especially among researchers working outside proteomics.
The last week has seen several COVID-19 publications from proteomics groups as the field explores what it can add to drug and diagnostics development.
Researchers at the laboratory have developed a single-cell proteomics workflow capable of reproducibly quantifying 1,000-plus proteins per cell.
The method could prove useful for applications like single-cell proteomics where datasets often have small numbers of high-quality peptide identifications.
The company is currently building out its product portfolio to include additional cytokine profiling panels as well as tools for single-cell phosphoproteomics.
The agency aims to aid adoption of NGS within public health labs, which have significantly increased their use of the technology in recent years.
The company expects that Blueprint's informatics capabilities in particular will improve variant interpretation and reporting across all its genetic test offerings.
The rise of new protein analysis techniques have some questioning whether mass spec will in coming years retain its dominant position within proteomics.
The 2010s saw major strides made through several large-scale initiatives aimed at mapping the human proteome and developing approaches for clinical work.
Researchers' picks range from emerging tools like deep learning to fundamental issues like false discovery rates and infrastructure for mass spec data sharing.
Kelvin Droegemeier, the director of the White House Office of Science and Technology Policy, is the new acting director of the US National Science Foundation.
An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.
Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.
In Nature this week: direct-capture Perturb-seq approach for combinatorial single-cell CRISPR screens, potential uses of genome-editing in breeding crops, and more.